ストックスクリーナーアプリを入手
0.9301
2.09%
-0.0199
アフターアワーズ：
.92
-0.0101
-1.09%
前日終値:
$0.95
開ける：
$0.959
24時間の取引高:
25,821
Relative Volume:
0.11
時価総額：
$4.73M
収益：
-
当期純損益:
$-21.13M
株価収益率:
-0.1942
EPS:
-4.79
ネットキャッシュフロー:
$-16.95M
1週間 パフォーマンス:
-3.11%
1か月 パフォーマンス:
-3.53%
6か月 パフォーマンス:
+52.48%
1年 パフォーマンス:
+449.06%
1日の値動き範囲:
$0.92
$0.965
1週間の範囲:
$0.92
$1.0034
52週間の値動き範囲:
$0.09
$4.49
Matinas Biopharma Holdings Inc Stock (MTNB) Company Profile
名前
Matinas Biopharma Holdings Inc
セクター
電話
908-443-1860
住所
1545 Route 206 South, Suite 302, Bedminster, NJ
MTNB を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
MTNB
Matinas Biopharma Holdings Inc
|
0.9301 | 4.83M | 0 | -21.13M | -16.95M | -4.79 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.65 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.10 | 60.96B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.81 | 42.77B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.99 | 36.21B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.47 | 32.08B | 3.81B | -644.79M | -669.77M | -6.24 |
Matinas Biopharma Holdings Inc Stock (MTNB) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2021-05-11 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2020-08-26 | 再開されました | Piper Sandler | Overweight |
| 2020-01-27 | 開始されました | Piper Sandler | Overweight |
| 2020-01-24 | 開始されました | SunTrust | Buy |
| 2020-01-23 | 開始されました | SunTrust | Buy |
| 2020-01-09 | 開始されました | Aegis Capital | Buy |
| 2019-06-26 | 開始されました | H.C. Wainwright | Buy |
すべてを表示
Matinas Biopharma Holdings Inc (MTNB) 最新ニュース
Is Matinas BioPharma Holdings Inc. a good long term investmentLightning-fast growth - PrintWeekIndia
What drives Matinas BioPharma Holdings Inc. stock priceMarket-beating returns - PrintWeekIndia
What analysts say about Matinas BioPharma Holdings Inc. stockExceptional market positioning - Autocar Professional
Matinas BioPharma Holdings Inc. Stock Analysis and ForecastOutstanding capital growth - PrintWeekIndia
What analysts say about HASI stockFree Investment Timing Strategies - jammulinksnews.com
How Matinas BioPharma Holdings Inc. stock performs during market volatilitySmart Return Focused Trading - Newser
Is Renovaro Inc. a good long term investmentSuperior capital gains - jammulinksnews.com
What makes Matinas BioPharma Holdings Inc. stock price move sharplyShort Squeeze Radar - beatles.ru
What analysts say about WRAP stockOutstanding capital returns - jammulinksnews.com
Why Matinas BioPharma Holdings Inc. stock attracts strong analyst attentionQuick Profit Idea Stream - Newser
Why Hayward Holdings Inc. stock attracts strong analyst attentionFree Stock Movement Tracking - Newser
Aspergillosis Pipeline 2025: FDA Updates, Therapy - openPR.com
Diversification Wins: Global ETFs Shine in First Half of 2025 - The Globe and Mail
Matinas BioPharma Approves 2025 Equity Incentive Plan - TipRanks
MTNB’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - investchronicle.com
Pre-market Movers: HCTI, KLTO, INTS, HSDT... - RTTNews
Kalkine Matinas BioPharma Surges Amid NYSE Composite Market Momentum - Kalkine Media
Matinas Biopharma (NYSE:MTNB) Trading 5.7% Higher – Here’s Why - Defense World
Matinas Biopharma (NYSE:MTNB) versus Marker Therapeutics (NASDAQ:MRKR) Head to Head Review - Defense World
Matinas BioPharma amends bylaws, updates on officer agreements By Investing.com - Investing.com Canada
Matinas BioPharma Amends Bylaws and Sets Annual Meeting - TipRanks
Matinas BioPharma amends bylaws, updates on officer agreements - Investing.com
Press Release Distribution & PR Platform - ACCESS Newswire
Matinas Biopharma Holdings Inc (MTNB) 財務データ
収益
当期純利益
現金流量
EPS
0.97%
0.22%
大文字化:
|
ボリューム (24 時間):